iwCLL 2019 | Utilizing the NOTCH1 pathway in CLL treatment

Silvia Deaglio

Silvia Deaglio, MD, PhD, University of Turin, Turin, Italy, describes the mechanisms by which NOTCH1 mutations can cause chronic lymphocytic leukemia (CLL) and the how we can target treatment with this knowledge. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Share this video